Cell Biology and Physiology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
J Neurochem. 2020 Sep;154(5):547-561. doi: 10.1111/jnc.14969. Epub 2020 Feb 5.
Parkinson's disease (PD) results from the selective loss of dopaminergic neurons of substantia nigra pars compacta region of the midbrain. It has been reported that the transcription factor forkhead Box O3a (FoxO3a) is activated and induces pro-apoptotic protein such as Bcl-2-interacting mediator of cell death (BIM) and p53 up-regulated modulator of apoptosis (PUMA) in variety of neuron death paradigms. Activity of FoxO3a is governed by its post-translational modifications which control its subcellular localization. Aim of this study was to determine whether FoxO3a is activated and up-regulates its pro-apoptotic genes to induce neuron death in PD. We exposed neuronal PC12 cells or primary cultures of dopaminergic neurons to 6-hydroxy dopamine (6-OHDA) and infused 6-OHDA in rat brain to develop PD models. We found that FoxO3a undergoes multiple post-translational modifications which render its nuclear localization in dopaminergic neuronal cells in response to 6-OHDA. The nuclear redistribution of FoxO3a is significantly increased in dopaminergic neurons of 6-OHDA infused rat brains as well. Moreover, FoxO3a is required for dopaminergic neurodegeneration in response to 6-OHDA as RNAi-mediated silencing of FoxO3a protects these cells from 6-OHDA toxicity. In a search of the downstream targets we identified PUMA as a direct target of FoxO3a. By knocking down FoxO3a we could successfully block the up-regulation of the pro-apoptotic protein PUMA in this model. Recently, it has been reported that chromatin remodeler SWItch/sucrose non-fermentable binds to FOXO and activates transcription. We found that Brg-associated factor 57 (BAF57), a subclass of SWItch/sucrose non-fermentable is up-regulated and play a necessary role in neuron death induced by 6-OHDA. Moreover, it is required for induction of PUMA by FoxO3a in this cellular model of PD. Taken together, our study suggest that FoxO3a is activated, translocates to nucleus, induces its pro-apoptotic target PUMA in the presence of chromatin remodeler BAF57 to execute neuron death in cellular models of PD.
帕金森病(PD)是由中脑黑质致密部的多巴胺能神经元选择性丧失引起的。据报道,转录因子叉头框 O3a(FoxO3a)在多种神经元死亡模型中被激活,并诱导促凋亡蛋白如 Bcl-2 相互作用介导体亡(BIM)和 p53 上调凋亡调节因子(PUMA)。FoxO3a 的活性受其翻译后修饰的控制,这些修饰控制其亚细胞定位。本研究的目的是确定 FoxO3a 是否被激活并上调其促凋亡基因,以诱导 PD 中的神经元死亡。我们将神经元 PC12 细胞或多巴胺能神经元原代培养物暴露于 6-羟基多巴胺(6-OHDA)中,并在大鼠脑中输注 6-OHDA 以建立 PD 模型。我们发现 FoxO3a 经历多种翻译后修饰,使其在多巴胺能神经元细胞中发生核定位,以响应 6-OHDA。FoxO3a 的核再分布在 6-OHDA 输注大鼠脑中的多巴胺能神经元中也显著增加。此外,FoxO3a 是多巴胺能神经退行性变所必需的,因为 FoxO3a 的 RNAi 介导沉默可保护这些细胞免受 6-OHDA 的毒性。在寻找下游靶标时,我们确定了 PUMA 是 FoxO3a 的直接靶标。通过敲低 FoxO3a,我们可以成功阻止该模型中促凋亡蛋白 PUMA 的上调。最近,有报道称染色质重塑剂 SWItch/sucrose non-fermentable 与 FOXO 结合并激活转录。我们发现,SWItch/sucrose non-fermentable 的一个亚类 Brg-associated factor 57(BAF57)上调,并在 6-OHDA 诱导的神经元死亡中发挥必要作用。此外,它是 FoxO3a 在这个 PD 细胞模型中诱导 PUMA 的必需因子。总之,我们的研究表明,FoxO3a 在存在染色质重塑剂 BAF57 的情况下被激活、易位到细胞核,并诱导其在 PD 细胞模型中执行神经元死亡的促凋亡靶标 PUMA。